Soluble S100A4 can directly activate the protein kinase B (Akt) signaling pathway to prolong CD8+ T cell survival [89] and promote SLE development [90, 91] through the ability of CD8+ T cells to create autoantibodies and cause organ damage [92]. This evidence concerns the gene CD8A and systemic lupus erythematosus.